These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 37476492)

  • 1. A systematic review and meta-analysis of cohort studies on the potential association between NAFLD/MAFLD and risk of incident atrial fibrillation.
    Zhou BG; Ju SY; Mei YZ; Jiang X; Wang M; Zheng AJ; Ding YB
    Front Endocrinol (Lausanne); 2023; 14():1160532. PubMed ID: 37476492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonalcoholic fatty liver disease is associated with increased risk of atrial fibrillation.
    Cai X; Zheng S; Liu Y; Zhang Y; Lu J; Huang Y
    Liver Int; 2020 Jul; 40(7):1594-1600. PubMed ID: 32279432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between non-alcoholic fatty liver disease and risk of atrial fibrillation in adult individuals: An updated meta-analysis.
    Mantovani A; Dauriz M; Sandri D; Bonapace S; Zoppini G; Tilg H; Byrne CD; Targher G
    Liver Int; 2019 Apr; 39(4):758-769. PubMed ID: 30657626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-alcoholic fatty liver disease increases the risk of cardiovascular disease in young adults and children: a systematic review and meta-analysis of cohort studies.
    Liao YL; Zhu GY; Chang C
    Front Cardiovasc Med; 2023; 10():1291438. PubMed ID: 38268853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of cardiovascular events in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis.
    Alon L; Corica B; Raparelli V; Cangemi R; Basili S; Proietti M; Romiti GF
    Eur J Prev Cardiol; 2022 May; 29(6):938-946. PubMed ID: 34939092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between non-alcoholic fatty liver disease and risk of new-onset atrial fibrillation in healthy adults.
    Roh JH; Lee JH; Lee H; Yoon YH; Kim M; Kim YG; Park GM; Park JH; Seong IW
    Liver Int; 2020 Feb; 40(2):338-346. PubMed ID: 31479572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High liver fibrosis scores in metabolic dysfunction-associated fatty liver disease patients are associated with adverse atrial remodeling and atrial fibrillation recurrence following catheter ablation.
    Decoin R; Butruille L; Defrancq T; Robert J; Destrait N; Coisne A; Aghezzaf S; Woitrain E; Gouda Z; Schino S; Klein C; Maboudou P; Brigadeau F; Klug D; Vincentelli A; Dombrowicz D; Staels B; Montaigne D; Ninni S
    Front Endocrinol (Lausanne); 2022; 13():957245. PubMed ID: 36120456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic dysfunction-associated fatty liver disease and risk of incident chronic kidney disease: A nationwide cohort study.
    Jung CY; Koh HB; Park KH; Joo YS; Kim HW; Ahn SH; Park JT; Kim SU
    Diabetes Metab; 2022 Jul; 48(4):101344. PubMed ID: 35346856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of circulating omentin level and metabolic-associated fatty liver disease: a systematic review and meta-analysis.
    Zhang Q; Chen S; Ke Y; Li Q; Shen C; Ruan Y; Wu K; Hu J; Liu S
    Front Endocrinol (Lausanne); 2023; 14():1073498. PubMed ID: 37139340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastrointestinal cancers in lean individuals with non-alcoholic fatty liver disease: A systematic review and meta-analysis.
    Souza M; Diaz I; Barchetta I; Mantovani A
    Liver Int; 2024 Jan; 44(1):6-14. PubMed ID: 37833849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between metabolic dysfunction-associated steatotic liver disease and risk of incident pancreatic cancer: a systematic review and meta-analysis of cohort studies.
    Zhang Y; Zhou BG; Zhan JD; Du BB
    Front Oncol; 2024; 14():1366195. PubMed ID: 38567158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonalcoholic fatty liver disease without overlapping metabolic-associated fatty liver disease and the risk of incident type 2 diabetes.
    Cho Y; Chang Y; Ryu S; Wild SH; Byrne CD
    Liver Int; 2023 Nov; 43(11):2445-2454. PubMed ID: 37387519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of nonalcoholic fatty liver disease with new-onset atrial fibrillation stratified by age groups.
    Cho EJ; Chung GE; Yoo JJ; Cho Y; Lee KN; Shin DW; Kim YJ; Yoon JH; Han K; Yu SJ
    Cardiovasc Diabetol; 2024 Sep; 23(1):340. PubMed ID: 39267090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of non-alcoholic fatty liver and metabolic-associated fatty liver with COVID-19 outcomes: A systematic review and meta-analysis.
    Jagirdhar GSK; Qasba RK; Pattnaik H; Rama K; Banga A; Reddy ST; Flumignan Bucharles AC; Kashyap R; Elmati PR; Bansal V; Bains Y; DaCosta T; Surani S
    World J Gastroenterol; 2023 Jun; 29(21):3362-3378. PubMed ID: 37377589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of all-cause mortality associated with non-alcoholic fatty liver disease and metabolic dysfunction-associated fatty liver disease in Taiwan MJ cohort.
    Cheng WC; Chen HF; Cheng HC; Li CY
    Epidemiol Health; 2024; 46():e2024024. PubMed ID: 38317531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonalcoholic fatty liver disease and the risk of atrial fibrillation stratified by body mass index: a nationwide population-based study.
    Lee SR; Han KD; Choi EK; Oh S; Lip GYH
    Sci Rep; 2021 Feb; 11(1):3737. PubMed ID: 33580177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global epidemiology of type 2 diabetes in patients with NAFLD or MAFLD: a systematic review and meta-analysis.
    Cao L; An Y; Liu H; Jiang J; Liu W; Zhou Y; Shi M; Dai W; Lv Y; Zhao Y; Lu Y; Chen L; Xia Y
    BMC Med; 2024 Mar; 22(1):101. PubMed ID: 38448943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic Dysfunction-associated Fatty Liver Disease and Mortality Among Chinese Adults: a Prospective Cohort Study.
    Wang X; Wu S; Yuan X; Chen S; Fu Q; Sun Y; Lan Y; Hu S; Wang Y; Lu Y; Qu S; Wang L
    J Clin Endocrinol Metab; 2022 Jan; 107(2):e745-e755. PubMed ID: 34467980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association of non-alcoholic fatty liver disease and atrial fibrillation: a review.
    Käräjämäki AJ; Hukkanen J; Ukkola O
    Ann Med; 2018 Aug; 50(5):371-380. PubMed ID: 29929399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NAFLD and MAFLD independently increase the risk of major adverse cardiovascular events (MACE): a 20-year longitudinal follow-up study from regional Australia.
    Vaz K; Kemp W; Majeed A; Lubel J; Magliano DJ; Glenister KM; Bourke L; Simmons D; Roberts SK
    Hepatol Int; 2024 Aug; 18(4):1135-1143. PubMed ID: 39008030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.